Inhibitors of Selected Bacterial Metalloenzymes - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Current Medicinal Chemistry Année : 2019

Inhibitors of Selected Bacterial Metalloenzymes


The utilization of bacterial metalloenzymes, especially ones not having mammalian (human) counterparts, has drawn attention to develop novel antibacterial agents to overcome drug resistance and especially multidrug resistance. In this review, we focus on the recent achievements on the development of inhibitors of bacterial enzymes peptide deformylase (PDF), metallo-β-lactamase (MBL), methionine aminopeptidase (MetAP) and UDP-3-O-acyl- N-acetylglucosamine deacetylase (LpxC). The state of the art of the design and investigation of inhibitors of bacterial metalloenzymes is presented, and challenges are outlined and discussed.
Fichier non déposé

Dates et versions

hal-03621741 , version 1 (28-03-2022)



Raivis Žalubovskis, Jean-Yves Winum. Inhibitors of Selected Bacterial Metalloenzymes. Current Medicinal Chemistry, 2019, 26 (15), pp.2690-2714. ⟨10.2174/0929867325666180403154018⟩. ⟨hal-03621741⟩
13 Consultations
0 Téléchargements



Gmail Mastodon Facebook X LinkedIn More